RWD149 Real-World Comparison of Cardiovascular Benefits between Sodium-Glucose Cotransporter 2 (SGLT-2I) and Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Inhibitors in Patients with Type 2 Diabetes (T2D)

Autor:	Huang, D., Greenwood, B., Salsabili, M., Tesell, M., Alcusky, M.
Zdroj:	In Value in Health June 2023 26(6) Supplement:S389-S389
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect